research

Akebia Therapeutics, Inc. (AKBA) Q4 2025 Earnings Call Transcript

Seeking Alpha

2 min read

0 likes

⚡ Quantum Brief

Akebia Therapeutics held its Q4 2025 earnings call on February 26, 2026, led by CEO John Butler and CFO Erik Ostrowski, detailing financial results and business updates. Key executives, including Chief Commercial Officer Nick Grund, highlighted Vafseo’s upcoming data presentation at the Annual Dialysis Conference in Kansas City, signaling progress in renal disease treatments. The company issued a press release with full-year 2025 financials, available on its investor relations website, emphasizing transparency ahead of the call. Forward-looking statements were noted, with warnings about potential risks affecting future results, a standard disclosure for earnings calls. A replay of the call was made available post-event, ensuring accessibility for investors and analysts reviewing the quarter’s performance.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

SA Transcripts158.65K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Akebia Therapeutics, Inc. (AKBA) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Company Participants Mercedes Carrasco - Senior Director of Investor & Corporate CommunicationsJohn Butler - CEO, President & DirectorNicholas Grund - Senior VP & Chief Commercial OfficerErik Ostrowski - Chief Business Officer, Senior VP, CFO & TreasurerSteven Burke - Senior VP and Chief Research & Development Officer Conference Call Participants Julian Harrison - BTIG, LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to Akebia's Fourth Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Mercedes Carrasco, Senior Director of IR. Please go ahead. Mercedes CarrascoSenior Director of Investor & Corporate Communications Thank you, and welcome to Akebia's Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call. Please note that a press release was issued earlier today, Thursday, February 26, detailing our fourth quarter and full year 2025 financial results, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will be available on our website after we conclude. Joining me for today's call, we have John Butler, Chief Executive Officer; Nick Grund, Chief Commercial Officer; and Erik Ostrowski, Chief Financial and Chief Business Officer. Dr. Steven Burke, our Chief Medical Officer and Head of Research and Development, is available for Q&A dialing in from the Annual Dialysis Conference in Kansas City today, where Akebia will present data on Vafseo this weekend. I'd like to remind everyone that this call includes forward-looking statements. Each forward-looking statement on this call is subject to risks and uncertainties that could cause actual results to differ materially from

Read Original

Source Information

Source: Seeking Alpha

Website: https://seekingalpha.com/feed.xml

Discussion

0 professional contributions

Be the first to add a constructive contribution.